Blog
-
The recent convertible bond issue by Telix Pharmaceuticals shines a light on the ongoing reopening of equity capital markets (ECM), driven by positive fundamentals on the equity side along with improved sentiments for growth-related investments. This deal highlights how companies are capitalising on favourable market conditions, raising funds while keeping risk in check. As made…
-
6 November 2022 When COVID-19 emerged in late 2019, it was framed primarily as a respiratory illness. Often described as “mild” for most who contracted it. But as months passed, thousands of patients began documenting persistent, debilitating symptoms that refused to resolve. Across blogs, social media threads, and online support groups, a new pattern of…